Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Offers Significant Advantages Over Current Standard Of Visualizing Bladder Cancer During Surgery
The number of bladder cancer cases in 2020 is estimated at 81,400, nearly 4.5% of all newly diagnosed cancer cases, and the current bladder cancer research market is projected to grow at a CAGR of 4.03% through 2026 White light, the most widely accepted current standard of care for bladder cancer removal, may not be the best option in helping to prevent recurrence, leaving hundreds of thousands of patients afraid of relapse Blue light has been introduced and proven to detect 25% more tumors, but because of limitations, has not been widely accepted Imagin Medical’s i/Blue Imaging System(TM) can be…